首页 > 最新文献

Bulletin de la Societe de pathologie exotique最新文献

英文 中文
Ne pas jeter le bébé avec l'eau de son bain. A propos d'Artemisia afra. 不要把婴儿和洗澡水一起倒掉。关于蒿属植物。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0089
J-F Pays
La publication du dernier rapport OMS sur le paludisme (novembre 2018, concernant l’année 2017) [3] constate que toutes les craintes qui avaient été formulées et reprises dans un ensemble de réflexions publié dans le Bulletin de la Société de pathologie exotique en 2010 [5] sont devenues aujourd’hui des réalités : quasi-stagnation depuis 2015 de la morbidité (219 millions de cas contre 239 millions en 2010) et de la mortalité (435 000 décès annuels, au lieu d’un chiffre proche de zéro promis pour 2015, si on s’en réfère aux objectifs du Programme mondial de lutte contre le paludisme lorsque celui-ci a pris le relai de Roll Back Malaria en 2010), échec de l’universalité de la couverture par les moustiquaires imprégnées d’insecticide à longue durée d’action (MILD ou MILDA) dont ne bénéficie aujourd’hui qu’une petite moitié de la population africaine à risque, associé à une résistance d’importance croissante des anophèles aux pyréthrinoïdes qui en sont le fer de lance, adaptation des vecteurs aux contraintes générées par l’ensemble des moyens de lutte antivectorielle...[3], tout cela dans le contexte d’une résistance de plus en plus préoccupante de P. falciparum aux combinaisons thérapeutiques à base d’artémisinine (CTA) et de l’entrée en scène d’un vaccin dont l’efficacité plus que médiocre (40 % dans le meilleur des cas), le condamnerait, en d’autres circonstances, à rester au placard [2]. Comme ces aristocrates de la Restauration dont Talleyrand disait qu’ils n’avaient rien oublié et rien appris, les responsables de la Stratégie technique mondiale de lutte contre le paludisme qui disposent aujourd’hui d’un budget annuel de 3 milliards de dollars, mais qui en réclament plus du double, s’étaient fixés en 2016, comme objectif intermédiaire 2020, une réduction de 40 % de la morbidité et de la mortalité du paludisme par rapport à 2015, et, à plus long terme, de 90 % en 2030. L’OMS a d’ores et déjà entériné le fait que les objectifs de moyen terme seront une fois de plus loin d’être atteints [4). Tout ce qui touche au traitement et à la prévention du paludisme à P. falciparum est donc plus que jamais d’actualité. Ce qu’il fallait dire au sujet de l’incitation à utiliser dans ce cadre, en monothérapie par voie orale et sous forme de tisane, donc à des doses qui ne peuvent être contrôlées, la plante dont est extraite l’artémisinine a été à juste titre dit à plusieurs reprises dans notre Bulletin et ailleurs. Il est un point sur lequel nous voudrions toutefois revenir : les tisanes préparées avec des feuilles séchées d’Artemisia afra feraient jeu égal avec celles d’Artemisia annua dans le traitement des accès de paludisme, alors qu’Artemisia afra ne contient pratiquement pas d’artémisinine (0,036 mg/gr de feuilles sèches versus 1,35 à 1,70 mg pour Artemisia annua). C’est du moins ce que prétendent les promoteurs et les défenseurs des tisanes d’Artemisia spp à la suite d’un essai randomisé en double insu [1] portant sur 943 patients et comparant respective
{"title":"Ne pas jeter le bébé avec l'eau de son bain. A propos d'Artemisia afra.","authors":"J-F Pays","doi":"10.3166/bspe-2019-0089","DOIUrl":"https://doi.org/10.3166/bspe-2019-0089","url":null,"abstract":"La publication du dernier rapport OMS sur le paludisme (novembre 2018, concernant l’année 2017) [3] constate que toutes les craintes qui avaient été formulées et reprises dans un ensemble de réflexions publié dans le Bulletin de la Société de pathologie exotique en 2010 [5] sont devenues aujourd’hui des réalités : quasi-stagnation depuis 2015 de la morbidité (219 millions de cas contre 239 millions en 2010) et de la mortalité (435 000 décès annuels, au lieu d’un chiffre proche de zéro promis pour 2015, si on s’en réfère aux objectifs du Programme mondial de lutte contre le paludisme lorsque celui-ci a pris le relai de Roll Back Malaria en 2010), échec de l’universalité de la couverture par les moustiquaires imprégnées d’insecticide à longue durée d’action (MILD ou MILDA) dont ne bénéficie aujourd’hui qu’une petite moitié de la population africaine à risque, associé à une résistance d’importance croissante des anophèles aux pyréthrinoïdes qui en sont le fer de lance, adaptation des vecteurs aux contraintes générées par l’ensemble des moyens de lutte antivectorielle...[3], tout cela dans le contexte d’une résistance de plus en plus préoccupante de P. falciparum aux combinaisons thérapeutiques à base d’artémisinine (CTA) et de l’entrée en scène d’un vaccin dont l’efficacité plus que médiocre (40 % dans le meilleur des cas), le condamnerait, en d’autres circonstances, à rester au placard [2]. Comme ces aristocrates de la Restauration dont Talleyrand disait qu’ils n’avaient rien oublié et rien appris, les responsables de la Stratégie technique mondiale de lutte contre le paludisme qui disposent aujourd’hui d’un budget annuel de 3 milliards de dollars, mais qui en réclament plus du double, s’étaient fixés en 2016, comme objectif intermédiaire 2020, une réduction de 40 % de la morbidité et de la mortalité du paludisme par rapport à 2015, et, à plus long terme, de 90 % en 2030. L’OMS a d’ores et déjà entériné le fait que les objectifs de moyen terme seront une fois de plus loin d’être atteints [4). Tout ce qui touche au traitement et à la prévention du paludisme à P. falciparum est donc plus que jamais d’actualité. Ce qu’il fallait dire au sujet de l’incitation à utiliser dans ce cadre, en monothérapie par voie orale et sous forme de tisane, donc à des doses qui ne peuvent être contrôlées, la plante dont est extraite l’artémisinine a été à juste titre dit à plusieurs reprises dans notre Bulletin et ailleurs. Il est un point sur lequel nous voudrions toutefois revenir : les tisanes préparées avec des feuilles séchées d’Artemisia afra feraient jeu égal avec celles d’Artemisia annua dans le traitement des accès de paludisme, alors qu’Artemisia afra ne contient pratiquement pas d’artémisinine (0,036 mg/gr de feuilles sèches versus 1,35 à 1,70 mg pour Artemisia annua). C’est du moins ce que prétendent les promoteurs et les défenseurs des tisanes d’Artemisia spp à la suite d’un essai randomisé en double insu [1] portant sur 943 patients et comparant respective","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 3","pages":"127-128"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37447067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation of the Follow-Up and State of Adolescents with Sickle-Cell Disease in Brazzaville (Congo)]. [对布拉柴维尔(刚果)青少年镰状细胞病随访和状况的评价]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0097
L C Ollandzobo Ikobo, F D Mouyabi Mberi, E R Nika, S V Missambou Mandilou, B S A Ngoulou, A B M'Pemba Loufoua, J R Mabiala-Babela

The experience of the adolescent with homozygous sickle-cell disease is influenced by several factors that differentiate it from the older child entirely dependent on his parents. The objective of this study was to describe the state of health and to assess the quality of follow-up and to identify the determinants of poor monitoring of adolescent sickle-cell followed in Brazzaville for an average of 12 ± 9.6 years, starting from a cross-sectional study carried out at the Brazzaville University Hospital from March to September 2016. It is based on a questionnaire composed of elements of assessment of the state of health and the quality of the follow-up. The vaccination coverage of adolescents was low, 81.3% for DTCP, 66.5% for Typhim Vi, 50.2% for viral hepatitis B, 76.4% for pneumococcus, and 59.1% for the ROR. In the last two years prior to the survey, 99 (48.7%) adolescents had only 2 follow-up visits instead of 4 planned per year. Therapeutic compliance was good in 132 (65%). No hospitalizations were reported during this period in 23 adolescents (11.3%); in 180 cases (88.7%), however, adolescents were hospitalized one to three times apart from regular follow-up visits. Since the discovery of the disease, 177 (87.2%) adolescents had already been transfused, more than three times in 89 cases. A history of neurovascular seizures was found in 10 cases (5.2%) and priapism in 35 cases (18.2%). Paraclinical examinations were not systematic during follow-up visits. The socioeconomic level of the family and the level of education of the father had a negative impact on monitoring and adherence (P < 0.01). On clinical examinations, stunting, undernutrition, pubertal delay, tooth decay, enuresis were found in 45.3%, 36%, 53.7%, 27.6%, 15.3%, respectively. The biological examinations carried out during the investigation showed an average inter-critical hemoglobin level between 7 and 8 g/dl, creatinine level was normal in all cases, ferritinemia was elevated in 93.6%, a negative proteinuria was found in 71.4% of the cases, and hematuria in 26.6%. Systematic abdominal ultrasound revealed vesicular lithiasis in 8 cases, hepatomegaly in 10 cases, and splenomegaly in 102 cases. Echocardiography performed in all subjects showed cardiomyopathy in 9 cases. The follow-up of the adolescent sickle-cell in Brazzaville still faces enormous difficulties. The improvement of the standard of living, the therapeutic education and the introduction of a total free of charge of the global management of sickle-cell disease would make it possible to minimize these difficulties which also would improve the future of these teenagers, adults of tomorrow.

患有纯合子镰状细胞病的青少年的经历受到若干因素的影响,这些因素使其与完全依赖父母的较大儿童有所区别。本研究的目的是从2016年3月至9月在布拉柴维尔大学医院进行的一项横断面研究开始,描述健康状况,评估随访质量,并确定布拉柴维尔平均12±9.6年青少年镰状细胞监测不良的决定因素。它以一份问卷为基础,由健康状况评估要素和后续行动的质量组成。青少年的疫苗接种率较低,DTCP接种率为81.3%,Typhim Vi为66.5%,病毒性乙型肝炎为50.2%,肺炎球菌为76.4%,ROR为59.1%。在调查前的最后两年,99名(48.7%)青少年只进行了2次随访,而不是每年计划的4次。治疗依从性良好的132例(65%)。在此期间,23名青少年(11.3%)未报告住院;然而,在180例(88.7%)病例中,除了定期随访外,青少年住院1至3次。自发现该病以来,已有177例(87.2%)青少年接受过输血,其中89例输血次数超过3次。有神经血管发作史10例(5.2%),勃起障碍35例(18.2%)。在随访期间没有系统的临床旁检查。家庭的社会经济水平和父亲的教育水平对监测和依从性有负向影响(P
{"title":"[Evaluation of the Follow-Up and State of Adolescents with Sickle-Cell Disease in Brazzaville (Congo)].","authors":"L C Ollandzobo Ikobo,&nbsp;F D Mouyabi Mberi,&nbsp;E R Nika,&nbsp;S V Missambou Mandilou,&nbsp;B S A Ngoulou,&nbsp;A B M'Pemba Loufoua,&nbsp;J R Mabiala-Babela","doi":"10.3166/bspe-2019-0097","DOIUrl":"https://doi.org/10.3166/bspe-2019-0097","url":null,"abstract":"<p><p>The experience of the adolescent with homozygous sickle-cell disease is influenced by several factors that differentiate it from the older child entirely dependent on his parents. The objective of this study was to describe the state of health and to assess the quality of follow-up and to identify the determinants of poor monitoring of adolescent sickle-cell followed in Brazzaville for an average of 12 ± 9.6 years, starting from a cross-sectional study carried out at the Brazzaville University Hospital from March to September 2016. It is based on a questionnaire composed of elements of assessment of the state of health and the quality of the follow-up. The vaccination coverage of adolescents was low, 81.3% for DTCP, 66.5% for Typhim Vi, 50.2% for viral hepatitis B, 76.4% for pneumococcus, and 59.1% for the ROR. In the last two years prior to the survey, 99 (48.7%) adolescents had only 2 follow-up visits instead of 4 planned per year. Therapeutic compliance was good in 132 (65%). No hospitalizations were reported during this period in 23 adolescents (11.3%); in 180 cases (88.7%), however, adolescents were hospitalized one to three times apart from regular follow-up visits. Since the discovery of the disease, 177 (87.2%) adolescents had already been transfused, more than three times in 89 cases. A history of neurovascular seizures was found in 10 cases (5.2%) and priapism in 35 cases (18.2%). Paraclinical examinations were not systematic during follow-up visits. The socioeconomic level of the family and the level of education of the father had a negative impact on monitoring and adherence (<i>P</i> < 0.01). On clinical examinations, stunting, undernutrition, pubertal delay, tooth decay, enuresis were found in 45.3%, 36%, 53.7%, 27.6%, 15.3%, respectively. The biological examinations carried out during the investigation showed an average inter-critical hemoglobin level between 7 and 8 g/dl, creatinine level was normal in all cases, ferritinemia was elevated in 93.6%, a negative proteinuria was found in 71.4% of the cases, and hematuria in 26.6%. Systematic abdominal ultrasound revealed vesicular lithiasis in 8 cases, hepatomegaly in 10 cases, and splenomegaly in 102 cases. Echocardiography performed in all subjects showed cardiomyopathy in 9 cases. The follow-up of the adolescent sickle-cell in Brazzaville still faces enormous difficulties. The improvement of the standard of living, the therapeutic education and the introduction of a total free of charge of the global management of sickle-cell disease would make it possible to minimize these difficulties which also would improve the future of these teenagers, adults of tomorrow.</p>","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 4","pages":"213-219"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37595582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Tribute to Professor Ogobara Doumbo: Symposium Organized by the COPED (Committee for Developing Countries) of the French Academy of Sciences - April 11, 2019, Simone and Cino del Duca Foundation]. [向Ogobara dunbo教授致敬:法国科学院COPED(发展中国家委员会)组织的研讨会- 2019年4月11日,Simone和Cino del Duca基金会]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0101
{"title":"[Tribute to Professor Ogobara Doumbo: Symposium Organized by the COPED (Committee for Developing Countries) of the French Academy of Sciences - April 11, 2019, Simone and Cino del Duca Foundation].","authors":"","doi":"10.3166/bspe-2019-0101","DOIUrl":"https://doi.org/10.3166/bspe-2019-0101","url":null,"abstract":"","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 4","pages":"220-239"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37595583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Scientific Day of the Société de pathologie exotique - Rodents in exotic pathology 29 May 2019, Institut Pasteur, Paris]. [2019年5月29日,巴黎巴斯德研究所,异国情调病理学学会科学日-异国情调病理学中的啮齿动物]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0081
J. Jannin, P. Marty, E. Pichard, P. Solano
{"title":"[Scientific Day of the Société de pathologie exotique - Rodents in exotic pathology 29 May 2019, Institut Pasteur, Paris].","authors":"J. Jannin, P. Marty, E. Pichard, P. Solano","doi":"10.3166/bspe-2019-0081","DOIUrl":"https://doi.org/10.3166/bspe-2019-0081","url":null,"abstract":"","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"32 1","pages":"119-123"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82174600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulmonary Metastase of a Knee Mycetoma in Senegal]. [塞内加尔一例膝关节足菌肿肺转移]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0091
L Sarr, A Diouf, K Diongue, B Dembélé, M Daffé, B A Diouf, A B Gueye, S Diao, N F Coulibaly, C Diémé, M H Sy

Mycetoma is transmitted by thorns infected. The commonest site for mycetoma is the foot. The primary pulmonary are rare and usually secondary to other primary site. We report a case of pulmonary fungal mycetoma secondary to primary site in the knee. We do a review of the literature and we discuss the way of dissemination.

足菌肿是由荆棘感染传播的。足菌肿最常见的部位是足部。原发肺少见,通常继发于其他原发部位。我们报告一例肺部真菌足菌肿继发于膝关节原发部位。我们对文献进行了回顾,并讨论了传播方式。
{"title":"[Pulmonary Metastase of a Knee Mycetoma in Senegal].","authors":"L Sarr,&nbsp;A Diouf,&nbsp;K Diongue,&nbsp;B Dembélé,&nbsp;M Daffé,&nbsp;B A Diouf,&nbsp;A B Gueye,&nbsp;S Diao,&nbsp;N F Coulibaly,&nbsp;C Diémé,&nbsp;M H Sy","doi":"10.3166/bspe-2019-0091","DOIUrl":"https://doi.org/10.3166/bspe-2019-0091","url":null,"abstract":"<p><p>Mycetoma is transmitted by thorns infected. The commonest site for mycetoma is the foot. The primary pulmonary are rare and usually secondary to other primary site. We report a case of pulmonary fungal mycetoma secondary to primary site in the knee. We do a review of the literature and we discuss the way of dissemination.</p>","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 3","pages":"129-132"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37447068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Second Day Dedicated to the Scientific Works of Young Doctors in French Guiana: Our Residents' Got Talent Université de la Guyane, Cayenne, French Guiana]. [法属圭亚那年轻医生科学工作的第二天:我们的居民有才能的大学,卡延,法属圭亚那]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0064
L Epelboin, M Douine, F Henaff, R Mutricy, A Lucarelli, T Bonifay, F Niemetzky
{"title":"[Second Day Dedicated to the Scientific Works of Young Doctors in French Guiana: <i>Our Residents' Got Talent</i> Université de la Guyane, Cayenne, French Guiana].","authors":"L Epelboin,&nbsp;M Douine,&nbsp;F Henaff,&nbsp;R Mutricy,&nbsp;A Lucarelli,&nbsp;T Bonifay,&nbsp;F Niemetzky","doi":"10.3166/bspe-2019-0064","DOIUrl":"https://doi.org/10.3166/bspe-2019-0064","url":null,"abstract":"","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 1","pages":"30-46"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37076658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reflections on Three Episodes of Louis Pasteur's Life as Seen in the William Dieterle's Movie (1936)]. [从威廉·迪特勒的电影中看到的路易斯·巴斯德的三段生活的反思(1936)]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0073
C T Daniel-Ribeiro, M M Lima, J-F Pays

Despite the criticism and reservations made about him still nowadays, Louis Pasteur may be considered one of the most important scientists of the last two centuries in public health, even if the work of the numerous scientists who preceded him have largely contributed to the successes he obtained without following too much to the rules of deontology and ethics currently in force in the world of research and medicine. He has definitively put down, by his experiments, the "theory of spontaneous generation" in force since antiquity, validated that of "germs or microbes", enacted the first rules of asepsis, while inspiring those of the antisepsis applied by Joseph Lister, and developed a certain number of vaccinations in veterinary and human medicine, including the anti-rabies, the one which made him famous all over the world. All this was not done without difficulty and Pasteur encountered for a large part of his life the misunderstanding of his contemporaries and the hostility of the medical world to which he did not belong. The authors comment in this text the movie The Story of Louis Pasteur by William Dieterle, filmed in 1936, based on the knowledge acquired since that date and doing the part of the real and the fiction.

尽管现在对他的批评和保留意见仍然存在,路易斯·巴斯德可能被认为是过去两个世纪中公共卫生领域最重要的科学家之一,即使在他之前的许多科学家的工作在很大程度上为他取得的成功做出了贡献,而没有过多地遵循目前在研究和医学领域有效的义务论和伦理学规则。他通过实验明确地确立了自古以来就有效的“自然发生论”,证实了“细菌或微生物”的理论,制定了无菌的第一个规则,同时启发了约瑟夫·李斯特(Joseph Lister)应用的防腐法,并在兽医和人类医学中开发了一定数量的疫苗,包括抗狂犬病疫苗,使他闻名于世。所有这些都不是一帆风顺的,巴斯德一生中大部分时间都遇到了同时代人的误解和他不属于的医学界的敌意。作者在这篇文章中评论了威廉·迪特勒于1936年拍摄的电影《路易斯·巴斯德的故事》,基于从那时起获得的知识,并做了真实和虚构的部分。
{"title":"[Reflections on Three Episodes of Louis Pasteur's Life as Seen in the William Dieterle's Movie (1936)].","authors":"C T Daniel-Ribeiro,&nbsp;M M Lima,&nbsp;J-F Pays","doi":"10.3166/bspe-2019-0073","DOIUrl":"https://doi.org/10.3166/bspe-2019-0073","url":null,"abstract":"<p><p>Despite the criticism and reservations made about him still nowadays, Louis Pasteur may be considered one of the most important scientists of the last two centuries in public health, even if the work of the numerous scientists who preceded him have largely contributed to the successes he obtained without following too much to the rules of deontology and ethics currently in force in the world of research and medicine. He has definitively put down, by his experiments, the \"theory of spontaneous generation\" in force since antiquity, validated that of \"germs or microbes\", enacted the first rules of asepsis, while inspiring those of the antisepsis applied by Joseph Lister, and developed a certain number of vaccinations in veterinary and human medicine, including the anti-rabies, the one which made him famous all over the world. All this was not done without difficulty and Pasteur encountered for a large part of his life the misunderstanding of his contemporaries and the hostility of the medical world to which he did not belong. The authors comment in this text the movie <i>The Story of Louis Pasteur</i> by William Dieterle, filmed in 1936, based on the knowledge acquired since that date and doing the part of the real and the fiction.</p>","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 1","pages":"22-29"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37076659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Assessment of Contraindications to Percutaneous Mitral Commissurotomy (PMC) in Abidjan Heart Institute, Côte d'Ivoire]. [阿比让心脏研究所经皮二尖瓣合并术(PMC)禁忌症评估,Côte d' ivire]。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0102
J T Niamkey, H Yao, F Traoré, A Ekou, I Angoran, D N B Koffi, M Kadio, J B Anzouan-Kacou

Rheumatic mitral stenosis is still common in sub-Saharan Africa. The aim of this study was to evaluate the clinical and echocardiographic contraindications to the realization of percutaneous mitral commissurotomy (PMC) in Abidjan Heart Institute. We conducted a prospective, transversal and analytical study in the Exploration Unit from March 30, 2017 to March 30, 2018. Mitral stenosis was severe with an average anatomical surface area of 0.87cm2, an average gradient of 13.7 mmHg and an upstream repercussion (dilatation of the left atrium (78 ml/m2); moderate dilatation of the right atrium (22.3 cm2) and average pulmonary arterial hypertension (PAH) of 55 mmHg). The main clinical contraindications were a history of rest dyspnoea at 66.7%, permanent atrial fibrillation at 53.3 % and clinical manifestations of severe PAH in 40 %. Unfavourable anatomy (95.7 %) evaluated by scores of Wilkins, Cormier and especially Echoscore revisited; bicommissural fusion (95.7 %) and severe aortic valvulopathy (31.1%) were the main barriers in transthoracic echocardiography. In multivariate analysis after linear regression, valvular anatomy, as assessed by the various scores, was significantly related to low socioeconomic status (p=0.018), level of education (p=0.04), severity of mitral stenosis evaluated by the mean gradient (p=0.033) and the impact on the left atrium (p=0.015). Mitral stenosis presents several clinical and echocardiographic contraindications. Adverse anatomy is the main obstacle and is related to low socio-economic status, educational level and severity of stenosis.

风湿性二尖瓣狭窄在撒哈拉以南非洲仍然很常见。本研究的目的是评估阿比让心脏研究所实施经皮二尖瓣合拢切开术(PMC)的临床和超声心动图禁忌症。2017年3月30日至2018年3月30日,我们在勘探单元进行了前瞻性、横向和分析性研究。二尖瓣狭窄严重,平均解剖表面积为0.87cm2,平均梯度为13.7 mmHg,上游返流(左心房扩张(78 ml/m2);右心房中度扩张(22.3 cm2),肺动脉高压(PAH)平均为55 mmHg)。主要临床禁忌症为静息性呼吸困难史(66.7%)、永久性房颤(53.3%)和重度PAH临床表现(40%)。经Wilkins, Cormier,尤其是Echoscore评分评价的不良解剖(95.7%);双侧融合(95.7%)和重度主动脉瓣病变(31.1%)是经胸超声心动图检查的主要障碍。在线性回归后的多变量分析中,各评分评估的瓣膜解剖与低社会经济地位(p=0.018)、教育水平(p=0.04)、平均梯度评估的二尖瓣狭窄严重程度(p=0.033)和对左心房的影响(p=0.015)显著相关。二尖瓣狭窄有几个临床和超声心动图禁忌症。不良解剖是主要障碍,与低社会经济地位、教育水平和狭窄严重程度有关。
{"title":"[Assessment of Contraindications to Percutaneous Mitral Commissurotomy (PMC) in Abidjan Heart Institute, Côte d'Ivoire].","authors":"J T Niamkey,&nbsp;H Yao,&nbsp;F Traoré,&nbsp;A Ekou,&nbsp;I Angoran,&nbsp;D N B Koffi,&nbsp;M Kadio,&nbsp;J B Anzouan-Kacou","doi":"10.3166/bspe-2019-0102","DOIUrl":"https://doi.org/10.3166/bspe-2019-0102","url":null,"abstract":"<p><p>Rheumatic mitral stenosis is still common in sub-Saharan Africa. The aim of this study was to evaluate the clinical and echocardiographic contraindications to the realization of percutaneous mitral commissurotomy (PMC) in Abidjan Heart Institute. We conducted a prospective, transversal and analytical study in the Exploration Unit from March 30, 2017 to March 30, 2018. Mitral stenosis was severe with an average anatomical surface area of 0.87cm<sup>2</sup>, an average gradient of 13.7 mmHg and an upstream repercussion (dilatation of the left atrium (78 ml/m<sup>2</sup>); moderate dilatation of the right atrium (22.3 cm<sup>2</sup>) and average pulmonary arterial hypertension (PAH) of 55 mmHg). The main clinical contraindications were a history of rest dyspnoea at 66.7%, permanent atrial fibrillation at 53.3 % and clinical manifestations of severe PAH in 40 %. Unfavourable anatomy (95.7 %) evaluated by scores of Wilkins, Cormier and especially Echoscore revisited; bicommissural fusion (95.7 %) and severe aortic valvulopathy (31.1%) were the main barriers in transthoracic echocardiography. In multivariate analysis after linear regression, valvular anatomy, as assessed by the various scores, was significantly related to low socioeconomic status (p=0.018), level of education (p=0.04), severity of mitral stenosis evaluated by the mean gradient (p=0.033) and the impact on the left atrium (p=0.015). Mitral stenosis presents several clinical and echocardiographic contraindications. Adverse anatomy is the main obstacle and is related to low socio-economic status, educational level and severity of stenosis.</p>","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 4","pages":"187-189"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37595578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)]. 在布拉柴维尔(刚果)用羟基脲治疗纯合子镰状细胞儿童。
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.3166/bspe-2019-0096
J R Mabiala-Babela, E R Nika, L C Ollandzobo Ikobo, A N Ofamalekou Gnakingue, B P S Ngoulou, S V Missambou Mandilou

The objective of this study is to reduce the morbidity of children with homozygous sickle cell disease presenting severe forms. We have conducted a longitudinal study between November 2015 and September 2017 at the Brazzaville University Hospital. Children with sickle cell disease requiring treatment with hydroxyurea were included. The variables studied were therapeutic compliance, evolutive profile of nutritional status, indications of hydroxyurea, electrophoresis of hemoglobin, blood count, and toxicity. The statistical test used was Student test with a significance threshold of less than 0.05. One thousand twenty-four children were monitored for sickle cell disease, 107 of which had received hydroxyurea (10.4%). The indications for hydroxyurea were recurrent anemic attacks (≥ 4) in 62 cases (57.9%), neurological crises 19 cases (17.8%), recurrent hyperalgesic crises in 17 cases (15.9%), priapism in 4 cases (3.7), and acute thoracic syndrome in 2 cases (1.9%). Therapeutic compliance was good in 89.5% of them. A rapid and lasting clinical improvement was noted in the majority of patients with hyperalgesic attacks (88.2%) and anemic attacks (88.7%), two recurrences for the cerebrovascular accidents, and an absence of recurrence of priapism and of the acute thoracic syndrome. From the biological point of view, there was a significant increase in fetal hemoglobin (1.2 to 16.2%; P  < 0.05), hemoglobin (7 to 8.3 g/dl; P < 0.05), mean cell volume (80.8 to 96 fl; P  < 0.05) and a significant decrease in mean white blood cell count (15,633 to 9,872/mm3; P  < 0.05) and platelets (387,002 to 324,400/mm3; P  < 0.05). The signs of toxicity observed were mainly vomiting and thrombocytopenia in two cases each, one case with headache and the other with neutropenia. Indications for use of hydroxyurea therapy in children with sickle cell disease in Brazzaville are common. These are dominated by recurrent anemic seizures, strokes, and hyperalgesic seizures. The excellent evolution of these complications under hydroxyurea represents an interesting alternative in our countries with limited resources.

本研究的目的是降低纯合子镰状细胞病患儿的发病率。我们于2015年11月至2017年9月在布拉柴维尔大学医院进行了一项纵向研究。需要用羟基脲治疗的镰状细胞病患儿被纳入研究对象。研究的变量包括治疗依从性、营养状况演变概况、羟脲适应症、血红蛋白电泳、血细胞计数和毒性。统计学检验为学生检验,显著性阈值小于0.05。对1224名儿童进行镰状细胞病监测,其中107名接受了羟基脲治疗(10.4%)。羟脲的适应症为复发性贫血发作(≥4)62例(57.9%)、神经危象19例(17.8%)、复发性痛觉过敏危象17例(15.9%)、阴茎勃起障碍4例(3.7)、急性胸综合征2例(1.9%)。89.5%的患者治疗依从性良好。大多数患者出现痛觉过敏发作(88.2%)和贫血发作(88.7%),两次脑血管意外复发,阴茎勃起和急性胸综合征无复发,均有快速和持久的临床改善。从生物学角度看,胎儿血红蛋白显著升高(1.2 ~ 16.2%);p3 p3 p3;页3;P
{"title":"[Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)].","authors":"J R Mabiala-Babela,&nbsp;E R Nika,&nbsp;L C Ollandzobo Ikobo,&nbsp;A N Ofamalekou Gnakingue,&nbsp;B P S Ngoulou,&nbsp;S V Missambou Mandilou","doi":"10.3166/bspe-2019-0096","DOIUrl":"https://doi.org/10.3166/bspe-2019-0096","url":null,"abstract":"<p><p>The objective of this study is to reduce the morbidity of children with homozygous sickle cell disease presenting severe forms. We have conducted a longitudinal study between November 2015 and September 2017 at the Brazzaville University Hospital. Children with sickle cell disease requiring treatment with hydroxyurea were included. The variables studied were therapeutic compliance, evolutive profile of nutritional status, indications of hydroxyurea, electrophoresis of hemoglobin, blood count, and toxicity. The statistical test used was Student test with a significance threshold of less than 0.05. One thousand twenty-four children were monitored for sickle cell disease, 107 of which had received hydroxyurea (10.4%). The indications for hydroxyurea were recurrent anemic attacks (≥ 4) in 62 cases (57.9%), neurological crises 19 cases (17.8%), recurrent hyperalgesic crises in 17 cases (15.9%), priapism in 4 cases (3.7), and acute thoracic syndrome in 2 cases (1.9%). Therapeutic compliance was good in 89.5% of them. A rapid and lasting clinical improvement was noted in the majority of patients with hyperalgesic attacks (88.2%) and anemic attacks (88.7%), two recurrences for the cerebrovascular accidents, and an absence of recurrence of priapism and of the acute thoracic syndrome. From the biological point of view, there was a significant increase in fetal hemoglobin (1.2 to 16.2%; <i>P</i>  < 0.05), hemoglobin (7 to 8.3 g/dl; <i>P</i> < 0.05), mean cell volume (80.8 to 96 fl; <i>P</i>  < 0.05) and a significant decrease in mean white blood cell count (15,633 to 9,872/mm<sup>3</sup>; <i>P</i>  < 0.05) and platelets (387,002 to 324,400/mm<sup>3</sup>; <i>P</i>  < 0.05). The signs of toxicity observed were mainly vomiting and thrombocytopenia in two cases each, one case with headache and the other with neutropenia. Indications for use of hydroxyurea therapy in children with sickle cell disease in Brazzaville are common. These are dominated by recurrent anemic seizures, strokes, and hyperalgesic seizures. The excellent evolution of these complications under hydroxyurea represents an interesting alternative in our countries with limited resources.</p>","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":"112 4","pages":"206-212"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37595581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Particularités de la prise en charge en Tunisie des séroconversions toxoplasmiques du troisième trimestre de grossesse 突尼斯妊娠晚期弓形虫血清转化治疗的特殊性
Q4 Medicine Pub Date : 2018-12-28 DOI: 10.3166/BSPE-2018-0054
Sabrine Bouhlel, R. Abdallah, Karim Aoun, R. Maatoug, O. Souissi, Aïda Bouratbine
{"title":"Particularités de la prise en charge en Tunisie des séroconversions toxoplasmiques du troisième trimestre de grossesse","authors":"Sabrine Bouhlel, R. Abdallah, Karim Aoun, R. Maatoug, O. Souissi, Aïda Bouratbine","doi":"10.3166/BSPE-2018-0054","DOIUrl":"https://doi.org/10.3166/BSPE-2018-0054","url":null,"abstract":"","PeriodicalId":9353,"journal":{"name":"Bulletin de la Societe de pathologie exotique","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46237113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bulletin de la Societe de pathologie exotique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1